Cary Street Partner Investment Advisory »

Verve Therapeutics shares owned by Cary Street Partner Investment Advisory

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Cary Street Partner Investment Advisory from 13F filings

Historical chart of Cary Street Partner Investment Advisory investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Cary Street Partner Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Cary Street Partner Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-09-30 $13k 1.0k 13.26
2023-06-30 $19k 1.0k 18.75
2023-03-31 $19k 1.3k 14.42
2022-12-31 $25k 1.3k 19.35

More positions owned by Cary Street Partner Investment Advisory

Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Vanguard Growth Etf Etf (VUG)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Adobe Stock (ADBE)
Amazon Stock (AMZN)
Vanguard Value Etf Etf (VTV)
Jpmorgan Equity Premium Income Etf Etf (JEPI)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Eafe Growth Etf Etf (EFG)
Vanguard Total Stock Market Etf Etf (VTI)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Texas Instrs Stock (TXN)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)

View all positions for Cary Street Partner Investment Advisory

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics